Chromaffin Cells
Overview
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Chromaffin Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000166](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000166)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000166](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000166)</td>
</tr>
</table>
Chromaffin Cells plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
<!-- taxonomy-enrichment --> [@alzheimers]
<!-- multi-taxonomy-enrichment --> [@nih]
Multi-Taxonomy Classification
Taxonomy Database Cross-References
PanglaoDB Marker Cross-References
External Database Links
...Chromaffin Cells
Overview
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Chromaffin Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000166](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000166)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000166](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000166)</td>
</tr>
</table>
Chromaffin Cells plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
<!-- taxonomy-enrichment --> [@alzheimers]
<!-- multi-taxonomy-enrichment --> [@nih]
Multi-Taxonomy Classification
Taxonomy Database Cross-References
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000166)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000166)
- [OBO Foundry (CL:0000166)](http://purl.obolibrary.org/obo/CL_0000166)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
- [PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000166)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000166)
- [OBO Foundry (CL:0000166)](http://purl.obolibrary.org/obo/CL_0000166)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [PanglaoDB](https://panglaodb.se/)
Introduction
Chromaffin Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{
"path": "cell-types/chromaffin-cells",
"title": "Chromaffin Cells",
"content": "# Chromaffin Cells\n\n## Overview\n\nChromaffin cells are neuroendocrine cells located in the adrenal medulla that synthesize, store, and release catecholamines (epinephrine, norepinephrine, and dopamine). These cells are of neural crest origin and represent a critical component of the sympathetic nervous system's neuroendocrine axis. They function as modified postganglionic sympathetic neurons that have lost their axons and became endocrine cells.\n\n## Morphology and Markers\n\n### Cellular Characteristics\n- Cell Body: Round to polygonal cell bodies, 15-25 μm in diameter\n- Cytoplasm: Abundant secretory granules (chromaffin granules) with electron-dense cores\n- Nucleus: Round nucleus with prominent nucleolus\n- Cell Types: \n - Epinephrine cells (80%)\n - Norepinephrine cells (15-20%)\n - Small granule-containing cells (D cells, 1-2%)\n\n### Molecular Markers\n- Tyrosine Hydroxylase (TH) - rate-limiting enzyme in catecholamine synthesis\n- Dopamine Beta-Hydroxylase (DBH) - converts dopamine to norepinephrine\n- Phenylethanolamine N-methyltransferase (PNMT) - converts norepinephrine to epinephrine\n- Chromogranin A/B - co-released with catecholamines\n- Synaptophysin - synaptic vesicle protein\n- PGP 9.5 (UCHL1) - neuronal marker\n- GATA3 - transcription factor\n- PHOX2B - master regulator of autonomic neuron development\n\n## Normal Function\n\n### Catecholamine Synthesis\nChromaffin cells produce catecholamines through a stepwise enzymatic pathway:\n1. Tyrosine → L-DOPA (tyrosine hydroxylase)\n2. L-DOPA → Dopamine (aromatic L-amino acid decarboxylase)\n3. Dopamine → Norepinephrine (dopamine β-hydroxylase)\n4. Norepinephrine → Epinephrine (phenylethanolamine N-methyltransferase)\n\n### Hormone Release\nStimulated by:\n- Acetylcholine from preganglionic sympathetic neurons (primary trigger)\n- Hypoglycemia\n- Stress\n- Exercise\n- Hypoxia\n\nRelease occurs via calcium-dependent exocytosis of chromaffin granules.\n\n### Physiological Roles\n- Fight-or-flight response: Epinephrine increases heart rate, blood pressure, and glucose availability\n- Metabolic regulation: Increases lipolysis, glycogenolysis, and gluconeogenesis\n- Vasomotor control: Norepinephrine causes vasoconstriction\n- Stress response: Central to hypothalamic-pituitary-adrenal (HPA) axis activation\n\n## Disease Vulnerability\n\n### Parkinson's Disease\n- Adrenal medulla shows reduced catecholamine content\n- Dysregulated sympathetic function in PD patients\n- Orthostatic hypotension from sympathetic denervation\n- Potential for chromaffin cell transplantation therapy\n\n### Multiple System Atrophy (MSA)\n- Early autonomic failure involves adrenal medulla dysfunction\n- Impaired catecholamine response to orthostatic stress\n- Postganglionic sympathetic neuron loss\n- Neurodegeneration of preganglionic input\n\n### Alzheimer's Disease\n- Altered catecholamine signaling in early disease\n- Reduced PNMT activity in some AD patients\n- Dysregulated stress response\n- Potential for noradrenergic therapeutic approaches\n\n### Diabetic Autonomic Neuropathy\n- Sympathetic denervation of adrenal medulla\n- Reduced catecholamine response to hypoglycemia\n- Impaired stress hormone counterregulation\n- Contributes to diabetic complications\n\n### Pheochromocytoma\n- Tumor of chromaffin cells\n- Excessive catecholamine secretion\n- Hypertension, tachycardia, sweating\n- Can be sporadic or hereditary (MEN2, NF1, VHL)\n\n### Neurodegeneration with Brain Iron Accumulation (NBIA)\n- Iron deposition in adrenal medulla\n- Oxidative stress vulnerability\n- Catecholamine dysregulation\n\n## Transcriptomic Profile\n\nChromaffin cells express a unique combination of:\n- Neuronal markers (PGP 9.5, Synapsin)\n- Neuroendocrine markers (Chromogranin, Secretogranin)\n- Adrenergic receptors\n- Ion channels (calcium, sodium, potassium)\n- Transcription factors (PHOX2B, ASCL1, GATA3)\n\n## Therapeutic Implications\n\n### Drug Targets\n- Alpha-2 adrenergic agonists - inhibit catecholamine release\n- Beta-blockers - block epinephrine/norepinephrine effects\n- Tyrosine hydroxylase inhibitors - reduce catecholamine synthesis\n- PNMT inhibitors - reduce epinephrine production\n\n### Cell-Based Therapies\n- Chromaffin cell transplantation for chronic pain\n- Potential for catecholamine replacement in autonomic disorders\n- Gene therapy approaches targeting catecholamine enzymes\n\n### Research Directions\n- Understanding chromaffin cell development from neural crest\n- Developing in vitro models from stem cells\n- Exploring sympathetic nervous system in neurodegeneration\n\n## See Also\n\n- Adrenal Medulla\n- Sympathetic Nervous System\n- Tyrosine Hydroxylase\n- Dopamine Beta-Hydroxylase\n- Pheochromocytoma\n- Autonomic Dysfunction\n- Parkinson's Disease\n- Multiple System Atrophy\n- HPA Axis\n\n
Overview
Chromaffin Cells plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Chromaffin Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
- [Tau Pathology](/mechanisms/tau-pathology)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [α-Synuclein](/proteins/alpha-synuclein)
References
[@neurodegenerative]: [Neurodegenerative Disease Research](https://www.ncbi.nlm.nih.gov/pmc/) - Comprehensive reviews on disease mechanisms
[@alzheimers]: [Alzheimer's Association](https://www.alz.org/) - Disease information and current research
[@nih]: [NIH National Institute on Aging](https://www.nia.nih.gov/) - Research updates and clinical trials
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data